AU Stock MarketDetailed Quotes
FRE Firebrick Pharma Ltd
- 0.053
- +0.002+3.92%
20min DelayMarket Closed Jul 5 13:15 AET
10.35MMarket Cap-1325P/E (Static)
0.053High0.053Low95.06KVolume0.053Open0.051Pre Close5.04KTurnover0.36052wk High0.11%Turnover Ratio195.31MShares0.03652wk Low-0.027EPS TTM4.79MFloat Cap0.750Historical HighLossP/E (Static)90.41MShs Float0.036Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM6.63P/B1Lot Size--Div YieldTTM
About Firebrick Pharma Ltd Company
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.
Company Profile
SymbolFRE
Company NameFirebrick Pharma Ltd
Founded2012
MarketASX
Fiscal Year Ends06-30
Address440 Collins Street Level 10
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 1300301874
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Stephen Francis Goodall
- Founder,Chief Operating Officer,Executive Director
- --
- Peter Laurence Molloy
- Founder,Chief Executive Officer,Executive Chairman,Executive Director
- --
- Richard Spencer Treagus
- Non-Executive Director
- --
- Phyllis Irene Gardner
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg